The success of allogeneic hematopoietic stem cell transplantation (HSCT) from matched unrelated donors (UDs) for beta-thalassemia may be hampered by the occurrence of graft rejection. Here, we show that the rate of this complication can be reduced by selecting 5-loci HLA-matched donors without nonpermissive mismatches at HLA-DPB1, defined according to an algorithm previously described and based on principles of central T-cell tolerance. Seventy-two consecutive patients and their UDs, prospectively selected for matching at the allelic level for HLA-A, -B, -C, -DRB, and -DQB1 loci, were enrolled in the analysis. These pairs were either DPB1 matched/permissively mismatched (n = 45, control group) or had at least one nonpermissive DPB1 mismatch...
HLA compatibility is a key factor for survival after unrelated hematopoietic stem cell transplantati...
Allogeneic bone marrow transplantation (BMT) from a genotypically identical family donor is an accep...
Hematopoietic stem cell transplantation (HSCT) with HLA-A, -B, -C, -DRB1, -DQB1 allele matched (10 o...
The success of allogeneic hematopoietic stem cell transplantation (HSCT) from matched unrelated dono...
The success of allogeneic hematopoietic stem cell transplantation (HSCT) from matched unrelated dono...
The importance of donor-recipient human leukocyte antigen (HLA)-DPB1 matching for the clinical outco...
The importance of donor-recipient human leukocyte antigen (HLA)-DPB1 matching for the clinical outco...
HLA compatibility is a significant factor in clinical allogeneic marrow transplantation. Disparity f...
AbstractHLA matching between the donor and recipient improves the success of unrelated hematopoietic...
BACKGROUND AND OBJECTIVES: Allogeneic bone marrow transplantation (BMT) is a widely accepted therape...
Allogeneic bone marrow transplantation (BMT) from a genotypically identical family donor is an accep...
HLA compatibility is a key factor for survival after unrelated hematopoietic stem cell transplantati...
Allogeneic bone marrow transplantation (BMT) from a genotypically identical family donor is an accep...
Hematopoietic stem cell transplantation (HSCT) with HLA-A, -B, -C, -DRB1, -DQB1 allele matched (10 o...
The success of allogeneic hematopoietic stem cell transplantation (HSCT) from matched unrelated dono...
The success of allogeneic hematopoietic stem cell transplantation (HSCT) from matched unrelated dono...
The importance of donor-recipient human leukocyte antigen (HLA)-DPB1 matching for the clinical outco...
The importance of donor-recipient human leukocyte antigen (HLA)-DPB1 matching for the clinical outco...
HLA compatibility is a significant factor in clinical allogeneic marrow transplantation. Disparity f...
AbstractHLA matching between the donor and recipient improves the success of unrelated hematopoietic...
BACKGROUND AND OBJECTIVES: Allogeneic bone marrow transplantation (BMT) is a widely accepted therape...
Allogeneic bone marrow transplantation (BMT) from a genotypically identical family donor is an accep...
HLA compatibility is a key factor for survival after unrelated hematopoietic stem cell transplantati...
Allogeneic bone marrow transplantation (BMT) from a genotypically identical family donor is an accep...
Hematopoietic stem cell transplantation (HSCT) with HLA-A, -B, -C, -DRB1, -DQB1 allele matched (10 o...